1. Home
  2. VECO vs RARE Comparison

VECO vs RARE Comparison

Compare VECO & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veeco Instruments Inc.

VECO

Veeco Instruments Inc.

HOLD

Current Price

$30.22

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Ultragenyx Pharmaceutical Inc.

RARE

Ultragenyx Pharmaceutical Inc.

HOLD

Current Price

$21.20

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VECO
RARE
Founded
1945
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
VECO
RARE
Price
$30.22
$21.20
Analyst Decision
Buy
Strong Buy
Analyst Count
5
19
Target Price
$27.25
$66.32
AVG Volume (30 Days)
1.1M
2.0M
Earning Date
05-28-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.31
EPS
0.59
N/A
Revenue
$664,294,000.00
$673,000,000.00
Revenue This Year
$18.35
$13.40
Revenue Next Year
$12.86
$42.83
P/E Ratio
$53.91
N/A
Revenue Growth
N/A
20.13
52 Week Low
$16.92
$18.41
52 Week High
$35.77
$40.54

Technical Indicators

Market Signals
Indicator
VECO
RARE
Relative Strength Index (RSI) 47.41 37.40
Support Level $27.79 $19.61
Resistance Level $33.48 $25.46
Average True Range (ATR) 1.74 0.98
MACD 0.14 0.03
Stochastic Oscillator 44.70 39.06

Price Performance

Historical Comparison
VECO
RARE

About VECO Veeco Instruments Inc.

Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The maximum of the company's revenue is generated from sales to the Semiconductor Industry and within China.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Share on Social Networks: